John C. Byrd

Also affiliated with University of Cincinnati

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 58 papers. Top paper: “The B-cell receptor signaling pathway as a therapeutic target in CLL”.

The B-cell receptor signaling pathway as a therapeutic target in CLL

Blood(2012)10.1182/blood-2012-02-362624

N/A

11.9DataRank · unranked

409 citations

Amy J. Johnson, John C. Byrd, Jennifer A. Woyach

Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2856

N/A

4.5DataRank · unranked

184 citations

Richard R. Furman, Steven Coutré, Ian W. Flinn, Jan A. Burger, Kristie A. Blum +9 more

Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia

Journal of Clinical Oncology(2020)10.1200/jco.20.00491

N/A

3.8DataRank · unranked

105 citations

Ying Huang, Amy S. Ruppert, Lynne V. Abruzzo, Barbara L. Andersen, Farrukh T. Awan +14 more

Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1130

N/A

3.1DataRank · unranked

79 citations

James S. Blachly, Kerry A. Rogers, Seema A. Bhat, Mojgan Jianfar, Gerard Lozanski +11 more

Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

Blood Advances(2020)10.1182/bloodadvances.2020002904

N/A

1.5DataRank · unranked

61 citations

Richard A. Larson, Dan Jones, Guido Marcucci, Thomas W. Prior, Jürgen Krauter +32 more

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Nature(2000)10.1038/35000501

N/A

1.4DataRank · unranked

9923 citations

Michael B. Eisen, R. Eric Davis, Chi Ma, Izidore S. Lossos, Andreas Rosenwald +32 more

Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3867

N/A

1.0DataRank · unranked

26 citations

Ying Huang, Amy S. Ruppert, Janek S. Walker, Daniel Canfield, Casey B. Cempre +13 more

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Blood Advances(2021)10.1182/bloodadvances.2021004233

N/A

1.0DataRank · unranked

30 citations

Guido Marcucci, Jun Yin, William Blum, Wendy Stock, Jessica Kohlschmidt +15 more

An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

Nature Cancer(2022)10.1038/s43018-022-00480-0

N/A

0.752DataRank · unranked

149 citations

Bettina Nadorp, Maarten Fornerod, Deedra Nicolet, Huiyun Wu, Christopher J. Walker +17 more

A precision medicine classification for treatment of acute myeloid leukemia in older patients

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01110-5

N/A

0.719DataRank · unranked

15 citations

Jessica Kohlschmidt, Uma Borate, James S. Blachly, Shelley Orwick, Ann-Kathrin Eisfeld +15 more

Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN

Blood(2025)10.1182/blood.2024024476

N/A

0.710DataRank · unranked

42 citations

Miklós Egyed, Wojciech Jurczak, Alan P Skarbnik, Krish Patel, Ian W. Flinn +22 more

Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7500

N/A

0.687DataRank · unranked

14 citations

Jun Yin, Jennifer R. Brown, Shira Dinner, Gerard Lozanski, Richard F. Little +15 more

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01032-2

N/A

0.601DataRank · unranked

54 citations

Zachary A. Hing, Bonnie K. Harrington, J.M. Baumhardt, Hatice Gülçin Özer, Amy Lehman +22 more

Clinical and functional significance of circular RNAs in cytogenetically normal AML

Blood Advances(2020)10.1182/bloodadvances.2019000568

N/A

0.561DataRank · unranked

41 citations

Stefano Volinia, Deedra Nicolet, Michał Świerniak, Andreas Petri, Krzysztof Mrózek +18 more

Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia

Blood Advances(2021)10.1182/bloodadvances.2020003727

N/A

0.553DataRank · unranked

39 citations

Krzysztof Mrózek, Hatice Gülçin Özer, Deedra Nicolet, Jessica Kohlschmidt, Dimitrios Papaioannou +13 more

VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia

Leukemia(2022)10.1038/s41375-022-01758-z

N/A

0.546DataRank · unranked

37 citations

Ethan C. Whipp, Janek S. Walker, Pu Zhang, Larry Beaver, Katie Williams +21 more

Association of social deprivation with survival in younger adult patients with AML: an Alliance study

Blood Advances(2023)10.1182/bloodadvances.2022009325

N/A

0.524DataRank · unranked

9 citations

Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, James S. Blachly +15 more

Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials

Blood Advances(2024)10.1182/bloodadvances.2023011307

N/A

0.442DataRank · unranked

18 citations

Jeff P. Sharman, Paolo Ghia, Jennifer A. Woyach, Toby A. Eyre, Wojciech Jurczak +7 more

High-dimensional genomic feature selection with the ordered stereotype logit model

Briefings in Bioinformatics(2022)10.1093/bib/bbac414

N/A

0.283DataRank · unranked

3 citations

Krzysztof Mrózek, Deedra Nicolet, Richard M. Stone, Ann‐Kathrin Eisfeld, John C. Byrd +2 more

Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia

The Innovation(2024)10.1016/j.xinn.2024.100719

N/A

0.269DataRank · unranked

5 citations

Han Fu, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, Geoffrey L. Uy +15 more

Optimizing extracellular vesicles’ isolation from chronic lymphocytic leukemia patient plasma and cell line supernatant

JCI Insight(2021)10.1172/jci.insight.137937

N/A

0.269DataRank · unranked

5 citations

Emanuele Cocucci, Ellen J. Sass, Xiaokui Mo, Angela R. Blissett, Edward Calomeni +8 more

Long-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapy

Haematologica(2024)10.3324/haematol.2024.285448

N/A

0.241DataRank · unranked

4 citations

Erika Borlenghi, Mark R. Litzow, John C. Byrd, Cristina Papayannidis, Cristina Tecchio +34 more

Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology)

Leukemia(2025)10.1038/s41375-025-02644-0

N/A

0.165DataRank · unranked

2 citations

Karilyn Larkin, Deedra Nicolet, Vindi Jurinović, Krzysztof Mrózek, Aarif M.N. Batcha +30 more

PTPN11 Mutation Clonal Hierarchy in Acute Myeloid Leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.18.612239

N/A

0.165DataRank · unranked

2 citations

Chia Sharpe, K. R. Quinn, K. Dawn Bryant, Linde A. Miles, Robert L. Bowman +24 more

Characterization and Mitigation of Fragmentation Enzyme-Induced Dual Stranded Artifacts

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.30.927491

N/A

0.104DataRank · unranked

1 citations

Apollinaire Ngankeu, Shelley Orwick, Esko A. Kautto, Jennifer A. Woyach, John C. Byrd +2 more

Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

UNC Libraries(2021)10.17615/vfd1-7m89

N/A

0DataRank · unranked

3 citations

Geoffrey R. Hill, Steven M. Devine, Jason A. Dubovsky, Samantha Jaglowski, Bruce R. Blazar +25 more

Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia

Cancer Discovery(2020)10.1158/2159-8290.cd-20-1579

N/A

0DataRank · unranked

83 citations

Jessica Kohlschmidt, Krzysztof Mrózek, Qiuhong Zhao, James L. Fisher, Deedra Nicolet +18 more

DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia

Genome Research(2021)10.1101/gr.269233.120

N/A

0DataRank · unranked

52 citations

Min Wang, Ada C Cleary, Yue-Zhong Wu, Anna Reister Schultz, Maximilian Schmutz +15 more

Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1280

N/A

0DataRank · unranked

4 citations

Qiuhong Zhao, Narendranath Epperla, Lindsey Rike, Xiaokui Mo, Mohamed Badawi +9 more

DNA Origami Nanostructures Elicit Dose‐Dependent Immunogenicity and Are Nontoxic up to High Doses In Vivo

Small(2022)10.1002/smll.202108063

N/A

0DataRank · unranked

106 citations

Patrick D. Halley, Amjad A. Chowdury, Bonnie K. Harrington, Larry Beaver, Rosa Lapalombella +6 more

Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma

Haematologica(2020)10.3324/haematol.2020.268235

N/A

0DataRank · unranked

17 citations

Vrajesh Karkhanis, Wing Keung Chan, Frankie Jeney, Alessandro Canella, Xiaoli Zhang +25 more

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

Journal of Hematology & Oncology(2022)10.1186/s13045-022-01302-7

N/A

0DataRank · unranked

39 citations

Leylah Azali, Lindsay Rosen, Qiuhong Zhao, Tracy Wiczer, Marilly Palettas +13 more

High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML

Blood Advances(2022)10.1182/bloodadvances.2022007544

N/A

0DataRank · unranked

35 citations

Deedra Nicolet, Benjamin Kelly, Krzysztof Mrózek, Stephanie LaHaye, Katherine E. Miller +25 more

Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid Leukemia

Cancers(2020)10.3390/cancers12061574

N/A

0DataRank · unranked

20 citations

Steven Sher, Katie Williams, Daniel Canfield, Shelley Orwick, Ronni Wasmuth +7 more

Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential

Cancers(2022)10.3390/cancers14235787

N/A

0DataRank · unranked

16 citations

John C. Byrd, Natarajan Muthusamy, Max Yano

Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib- and acalabrutinib-treated patients

Blood(2022)10.1182/blood.2021015132

N/A

0DataRank · unranked

11 citations

Xiaomeng Huang, 義行高橋, Szabolcs Tarapcsák, Kerry A. Rogers, Shrilekha Misra +5 more

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion

Cancers(2022)10.3390/cancers15010029

N/A

0DataRank · unranked

10 citations

Jack C. Stromatt, Sydney Fobare, Kevin M. Huang, Daelynn R. Buelow, Shelley Orwick +8 more

ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia

Leukemia Research(2022)10.1016/j.leukres.2022.106872

N/A

0DataRank · unranked

3 citations

Chi‐Ling Chiang, Kevan Zapolnik, Jessica Nunes, Ann Ventura, Xiaokui Mo +9 more

CLEAR: coverage-based limiting-cell experiment analysis for RNA-seq

Journal of Translational Medicine(2020)10.1186/s12967-020-02247-6

N/A

0DataRank · unranked

22 citations

Michael G. Sovic, Chi‐Ling Chiang, Eileen Hu, Jiyeon K. Denninger, Xi Chen +6 more

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

Frontiers in Oncology(2022)10.3389/fonc.2022.897280

N/A

0DataRank · unranked

3 citations

Xiao‐Jie Yan, Wentian Li, Emanuela M. Ghia, Anton W. Langerak, Laura Z. Rassenti +22 more

Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study

Leukemia(2023)10.1038/s41375-023-01846-8

N/A

0DataRank · unranked

74 citations

Jessica Kohlschmidt, James S. Blachly, Deedra Nicolet, Andrew J. Carroll, Kellie J. Archer +14 more

Genetic heterogeneity of diffuse large B-cell lymphoma

UNC Libraries(2020)10.17615/dkye-0q87

N/A

0DataRank · unranked

23 citations

Gopesh Srivastava, Leon Bernal‐Mizrachi, Eric D. Hsi, Katherine Walsh, Magdalena Czader +27 more

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study

Blood Advances(2023)10.1182/bloodadvances.2023010482

N/A

0DataRank · unranked

2 citations

Jessica Kohlschmidt, Shelley Orwick, Daelynn R. Buelow, Sydney Fobare, Christopher C. Oakes +12 more

Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia

Journal of Hematology & Oncology(2020)10.1186/s13045-019-0821-7

N/A

0DataRank · unranked

20 citations

Abeera Mehmood, Jae Yoon Jeon, Bridget Carmichael, Amy Lehman, Shelley Orwick +13 more

Data from Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6529547

N/A

0DataRank · unranked

0 citations

Qiuhong Zhao, Narendranath Epperla, Lindsey Rike, Xiaokui Mo, Mohamed Badawi +9 more

Data from Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6529547.v1

N/A

0DataRank · unranked

0 citations

Qiuhong Zhao, Narendranath Epperla, Lindsey Rike, Xiaokui Mo, Mohamed Badawi +9 more

Data from Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition

(2023)10.1158/1078-0432.c.6531362.v1

N/A

0DataRank · unranked

0 citations

Lindsey T. Brinton, Katie Williams, Steven Sher, Shelley Orwick, Tzung-Huei Lai +21 more

Data from Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

(2023)10.1158/1078-0432.c.6532472

N/A

0DataRank · unranked

0 citations

Ying Huang, Amy S. Ruppert, Janek S. Walker, Daniel Canfield, Casey B. Cempre +13 more

Management of CLL patients early in the COVID‐19 pandemic: An international survey of CLL experts

American Journal of Hematology(2020)10.1002/ajh.25851

N/A

0DataRank · unranked

21 citations

Anthony R. Mato, John C. Byrd, Alexey V. Danilov, Brad Hedrick, Chaitra S. Ujjani +6 more

Characterization and mitigation of fragmentation enzyme-induced dual stranded artifacts

NAR Genomics and Bioinformatics(2020)10.1093/nargab/lqaa070

N/A

0DataRank · unranked

22 citations

Apollinaire Ngankeu, Shelley Orwick, Esko A. Kautto, Jennifer A. Woyach, John C. Byrd +2 more

A Bayesian framework to study tumor subclone–specific expression by combining bulk DNA and single-cell RNA sequencing data

Genome Research(2024)10.1101/gr.278234.123

N/A

0DataRank · unranked

4 citations

Xiaomeng Huang, Philip J. Moos, Jonathan M. Ahmann, Anthony D. Pomicter, Michael W. Deininger +5 more

Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemia

Journal of Hematology & Oncology(2020)10.1186/s13045-020-00973-4

N/A

0DataRank · unranked

63 citations

Pu Zhang, Katie Williams, Daniel Canfield, Shelley Orwick, Steven Sher +12 more

DHODH inhibition alters T cell metabolism limiting acute graft-versus-host disease while retaining graft-versus-leukemia response

The Journal of Immunology(2025)10.1093/jimmun/vkaf023

N/A

0DataRank · unranked

0 citations

Kara M. Braunreiter, Lotus Neidemire-Colley, Natalie E. Sell, Yandi Gao, Camryn Steere +13 more

Toxicity burden in older patients with chronic lymphocytic leukemia (CLL) receiving bendamustine with rituximab (BR) or ibrutinib (IB) regimens: Alliance A041202.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e20004

N/A

0DataRank · unranked

0 citations

Sumithra J. Mandrekar, Allison M. Booth, Wei Ding, Nancy L. Bartlett, Danielle M. Brander +15 more

Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3724

N/A

0DataRank · unranked

33 citations

Lindsey T. Brinton, Katie Williams, Steven Sher, Shelley Orwick, Tzung-Huei Lai +21 more

Anti-tumor NAMPT inhibitor, KPT-9274, mediates gender-dependent murine anemia and nephrotoxicity by regulating SIRT3-mediated SOD deacetylation

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01107-0

N/A

0DataRank · unranked

21 citations

Pu Zhang, Matthew Cannon, Larry Beaver, Amy Lehman, Bonnie K. Harrington +4 more

Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01118-x

N/A

0DataRank · unranked

14 citations

Krzysztof Mrózek, Brian Giacopelli, Jessica Kohlschmidt, Deedra Nicolet, Dimitrios Papaioannou +10 more

Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia

Nature Communications(2021)10.1038/s41467-021-26400-x

N/A

0DataRank · unranked

9 citations

Zachary A. Hing, Steven Sher, J. Cronin, Katie Williams, Bonnie K. Harrington +20 more